Related references
Note: Only part of the references are listed.Heart Disease and Stroke Statistics-2014 Update A Report From the American Heart Association
Alan S. Go et al.
CIRCULATION (2014)
Recent developments in biased agonism
James W. Wisler et al.
CURRENT OPINION IN CELL BIOLOGY (2014)
Phase 1 Safety, Tolerability and Pharmacokinetics of 3K3A-APC in Healthy Adult Volunteers
Patrick Lyden et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
The Anticoagulant Activated Protein C (aPC) Promotes Metaplasticity in the Hippocampus Through an EPCR-PAR1-S1P1 Receptors Dependent Mechanism
Nicola Maggio et al.
HIPPOCAMPUS (2014)
Global stroke statistics
Amanda G. Thrift et al.
INTERNATIONAL JOURNAL OF STROKE (2014)
Acute Ischemic Stroke Time, Penumbra, and Reperfusion
Nathan W. Manning et al.
STROKE (2014)
Factors Influencing the Decline in Stroke Mortality A Statement From the American Heart Association/American Stroke Association
Daniel T. Lackland et al.
STROKE (2014)
Activated protein C based therapeutic strategies in chronic diseases
Fabian Bock et al.
THROMBOSIS AND HAEMOSTASIS (2014)
Advances and Challenges in Treatment and Prevention of Ischemic Stroke
Aaron W. Grossman et al.
ANNALS OF NEUROLOGY (2013)
Novel mechanisms for activated protein C cytoprotective activities involving noncanonical activation of protease-activated receptor 3
Laurent Burnier et al.
BLOOD (2013)
Neurotoxicity of the anticoagulant-selective E149A-activated protein C variant after focal ischemic stroke in mice
Yaoming Wang et al.
BLOOD CELLS MOLECULES AND DISEASES (2013)
Activated protein C analog promotes neurogenesis and improves neurological outcome after focal ischemic stroke in mice via protease activated receptor 1
Yaoming Wang et al.
BRAIN RESEARCH (2013)
Impact of Onset-to-Reperfusion Time on Stroke Mortality A Collaborative Pooled Analysis
Mikael Mazighi et al.
CIRCULATION (2013)
An Activated Protein C Analog Stimulates Neuronal Production by Human Neural Progenitor Cells via a PAR1-PAR3-S1PR1-Akt Pathway
Huang Guo et al.
JOURNAL OF NEUROSCIENCE (2013)
Mechanisms of anticoagulant and cytoprotective actions of the protein C pathway
E. A. M. Bouwens et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Quality of life after TIA and stroke Ten-year results of the Oxford Vascular Study
Ramon Luengo-Fernandez et al.
NEUROLOGY (2013)
High dose infusion of activated protein C (rhAPC) fails to improve neuronal damage and cognitive deficit after global cerebral ischemia in rats
Melanie Brueckner et al.
NEUROSCIENCE LETTERS (2013)
Activated Protein C Analog Protects From Ischemic Stroke and Extends the Therapeutic Window of Tissue-Type Plasminogen Activator in Aged Female Mice and Hypertensive Rats
Yaoming Wang et al.
STROKE (2013)
Novel Approaches to Neuroprotection Trials in Acute Ischemic Stroke
Michael Tymianski
STROKE (2013)
Review of Stroke Thrombolytics
Andrew Bivard et al.
JOURNAL OF STROKE (2013)
Molecular Mechanism of beta-Arrestin-Biased Agonism at Seven-Transmembrane Receptors
Eric Reiter et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52 (2012)
Cytoprotective signaling by activated protein C requires protease-activated receptor-3 in podocytes
Thati Madhusudhan et al.
BLOOD (2012)
Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46
Laurent O. Mosnier et al.
BLOOD (2012)
Preclinical Safety and Pharmacokinetic Profile of 3K3A-APC, a Novel, Modified Activated Protein C for Ischemic Stroke
Patricia D. Williams et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Thrombin Activity Associated with Neuronal Damage during Acute Focal Ischemia
Bo Chen et al.
JOURNAL OF NEUROSCIENCE (2012)
Allosteric Modulation of Protease-Activated Receptor Signaling
I. Canto et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2012)
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
Rafael Lozano et al.
LANCET (2012)
Drotrecogin Alfa (Activated) in Adults with Septic Shock
V. Marco Ranieri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
An Activated Protein C Analog With Reduced Anticoagulant Activity Extends the Therapeutic Window of Tissue Plasminogen Activator for Ischemic Stroke in Rodents
Yaoming Wang et al.
STROKE (2012)
Cytoprotective-Selective Activated Protein C Attenuates Pseudomonas aeruginosa-Induced Lung Injury in Mice
Nastasha Bir et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2011)
Multiple receptor-mediated functions of activated protein C
H. Weiler
HAMOSTASEOLOGIE (2011)
The Occupancy of Endothelial Protein C Receptor by its Ligand Modulates the PAR-1 Dependent Signaling Specificity of Coagulation Proteases
Alireza R. Rezaie
IUBMB LIFE (2011)
Activated Protein C N-Linked Glycans Modulate Cytoprotective Signaling Function on Endothelial Cells
Fionnuala Ni Ainle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Activated protein C promotes protease-activated receptor-1 cytoprotective signaling through β-arrestin and dishevelled-2 scaffolds
Unice J. K. Soh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The structure-function relationship of activated protein C Lessons from natural and engineered mutations
Karin C. A. A. Wildhagen et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Cytoprotective protein C pathways and implications for stroke and neurological disorders
Berislav V. Zlokovic et al.
TRENDS IN NEUROSCIENCES (2011)
The protein C pathway in tissue inflammation and injury: pathogenic role and therapeutic implications
Silvio Danese et al.
BLOOD (2010)
Activated protein C analog with reduced anticoagulant activity improves functional recovery and reduces bleeding risk following controlled cortical impact
Corey T. Walker et al.
BRAIN RESEARCH (2010)
Regulation of the Protein C Anticoagulant and Antiinflammatory Pathways
A. R. Rezaie
CURRENT MEDICINAL CHEMISTRY (2010)
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials
Kennedy R. Lees et al.
LANCET (2010)
Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: Critical role of matrix metalloproteinases and tissue-type plasminogen activator
Rong Jin et al.
NEUROBIOLOGY OF DISEASE (2010)
Blood-brain barrier permeability and tPA-mediated neurotoxicity
Rami Abu Fanne et al.
NEUROPHARMACOLOGY (2010)
ACTIVATED PROTEIN C PREVENTS GLUTAMATE- AND THROMBIN-INDUCED ACTIVATION OF NUCLEAR FACTOR-κB IN CULTURED HIPPOCAMPAL NEURONS
L. Gorbacheva et al.
NEUROSCIENCE (2010)
Thrombin Mediates Severe Neurovascular Injury During Ischemia
Bo Chen et al.
STROKE (2010)
Hyperantithrombotic, noncytoprotective Glu149Ala-activated protein C mutant
Laurent O. Mosnier et al.
BLOOD (2009)
Neuroprotective activities of activated protein C mutant with reduced anticoagulant activity
Huang Guo et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
Endothelial protein C receptor-assisted transport of activated protein C across the mouse blood-brain barrier
Rashid Deane et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2009)
Species-dependent neuroprotection by activated protein C mutants with reduced anticoagulant activity
Huang Guo et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Distinct Functions of Activated Protein C Differentially Attenuate Acute Kidney Injury
Akanksha Gupta et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
The protein C pathway and pathologic processes
F. J. Castellino et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Low protein C and incidence of ischemic stroke and coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study
A. R. Folsom et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Proteases Display Biased Agonism at Protease-Activated Receptors: Location Matters!
Angela Russo et al.
MOLECULAR INTERVENTIONS (2009)
Differential Neuroprotection and Risk for Bleeding From Activated Protein C With Varying Degrees of Anticoagulant Activity
Yaoming Wang et al.
STROKE (2009)
Dissociation of Activated Protein C Functions by Elimination of Protein S Cofactor Enhancement
Shona Harmon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Activated Protein C Promotes Neovascularization and Neurogenesis in Postischemic Brain via Protease-Activated Receptor 1
Meenakshisundaram Thiyagarajan et al.
JOURNAL OF NEUROSCIENCE (2008)
Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets
May H. Han et al.
NATURE (2008)
Activated protein C mutant with minimal anticoagulant activity, normal cytoprotective activity, and preservation of thrombin activable fibrinolysis inhibitor-dependent cytoprotective functions
Laurent O. Mosnier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Endotoxemia and sepsis mortality reduction by non-anticoagulant-activated protein C
Edward J. Kerschen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Identification of a specific exosite on activated protein C for interaction with protease-activated receptor 1
Likui Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization
Joseph N. McLaughlin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Engineering a disulfide bond to stabilize the calcium-binding loop of activated protein C eliminates its anticoagulant but not its protective signaling properties
Jong-Sup Bae et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Activated protein C inhibits tissue plasminogen activator-induced brain hemorrhage
Tong Cheng et al.
NATURE MEDICINE (2006)
Multifunctional specificity of the protein C/activated protein C Gla domain
Roger J. S. Preston et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Inflammation and the activated protein C anticoagulant pathway
Charles T. Esmon
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2006)
1,026 experimental treatments in acute stroke
VE O'Collins et al.
ANNALS OF NEUROLOGY (2006)
Functional recovery after embolic stroke in rodents by activated protein C
BV Zlokovic et al.
ANNALS OF NEUROLOGY (2005)
Protease-activated receptors in hemostasis, thrombosis and vascular biology
SR Coughlin
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3
H Guo et al.
NEURON (2004)
Activated protein C variants with normal cytoprotective but reduced anticoagulant activity
LO Mosnier et al.
BLOOD (2004)
Tissue plasminogen activator neurovascular toxicity is controlled by activated protein C
D Liu et al.
NATURE MEDICINE (2004)
Safety assessment of drotrecogin alfa (activated) in the treatment of adult patients with severe sepsis
GR Bernard et al.
CRITICAL CARE (2003)
Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective
T Cheng et al.
NATURE MEDICINE (2003)
Activated protein C:: Potential therapy for severe sepsis, thrombosis, and stroke
JH Griffin et al.
SEMINARS IN HEMATOLOGY (2002)
Anti-inflammatory, antithrombotic, and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke
M Shibata et al.
CIRCULATION (2001)
Efficacy and safety of recombinant human activated protein C for severe sepsis.
GR Bernard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Complete antithrombin deficiency in mice results in embryonic lethality
K Ishiguro et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
